SK Biopharmaceuticals restructures its organization, appointing Chey Yoon-jung as Head of Strategy Division and launching a new radiopharmaceuticals unit to drive future growth.
#YonhapInfomax #SKBiopharmaceuticals #CheyYoonJung #OrganizationalRestructuring #Radiopharmaceuticals #StrategyDivision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94009




